Darunavir

Paul A. Pham, Pharm.D., Janessa M. Smith, Pharm.D. BCPS, Alice Jenh Hsu, Pharm.D.
Darunavir is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • HIV-infected patients who are treatment-experienced and have at least one DRV resistance mutation, in combination with other antiretrovirals (DRV/r 600/100 mg twice daily).
  • HIV-infected patients who are treatment-naive (DRV/r 800/100 mg once daily or DRV/c 800/150 mg once daily).
  • HIV-infected children (>3 years)

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: January 12, 2016